Zobrazeno 1 - 6
of 6
pro vyhledávání: '"DiMarco AV"'
Autor:
Garcia NMG; Translational Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Center.; Department of Pharmacology and Cancer Biology, Duke University School of Medicine., Becerra JN; Translational Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Center., McKinney BJ; Translational Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Center., DiMarco AV; Department of Pharmacology and Cancer Biology, Duke University School of Medicine., Wu F; Genomics and Bioinformatics, Fred Hutchinson Cancer Center., Fitzgibbon M; Genomics and Bioinformatics, Fred Hutchinson Cancer Center., Alvarez JV; Translational Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Center.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Nov 20. Date of Electronic Publication: 2024 Nov 20.
Autor:
DiMarco AV; Department of Translational Oncology, Genentech, Inc., South San Francisco, California., Maddalo D; Department of Translational Oncology, Genentech, Inc., South San Francisco, California.
Publikováno v:
Current protocols [Curr Protoc] 2022 Mar; Vol. 2 (3), pp. e377.
Autor:
DiMarco AV; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina., Qin X; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina., McKinney BJ; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina., Garcia NMG; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina., Van Alsten SC; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Mendes EA; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina., Force J; Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Durham, North Carolina., Hanks BA; Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Durham, North Carolina., Troester MA; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Owzar K; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina., Xie J; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina., Alvarez JV; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina. james.alvarez@duke.edu.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2022 Jan; Vol. 10 (1), pp. 70-86. Date of Electronic Publication: 2021 Nov 18.
Autor:
Walens A; Department of Pharmacology and Cancer Biology, Duke University, Durham, United States., DiMarco AV; Department of Pharmacology and Cancer Biology, Duke University, Durham, United States., Lupo R; Department of Pharmacology and Cancer Biology, Duke University, Durham, United States., Kroger BR; Department of Pharmacology and Cancer Biology, Duke University, Durham, United States., Damrauer JS; Department of Pharmacology and Cancer Biology, Duke University, Durham, United States., Alvarez JV; Department of Pharmacology and Cancer Biology, Duke University, Durham, United States.
Publikováno v:
ELife [Elife] 2019 Apr 16; Vol. 8. Date of Electronic Publication: 2019 Apr 16.
Autor:
Ball JP; Research and Development Department, Nanotherapeutics, Inc., Alachua, Florida, United States of America., Springer MJ; Research and Development Department, Nanotherapeutics, Inc., Alachua, Florida, United States of America., Ni Y; Research and Development Department, Nanotherapeutics, Inc., Alachua, Florida, United States of America., Finger-Baker I; Research and Development Department, Nanotherapeutics, Inc., Alachua, Florida, United States of America., Martinez J; Research and Development Department, Nanotherapeutics, Inc., Alachua, Florida, United States of America., Hahn J; Research and Development Department, Nanotherapeutics, Inc., Alachua, Florida, United States of America., Suber JF; Research and Development Department, Nanotherapeutics, Inc., Alachua, Florida, United States of America., DiMarco AV; Research and Development Department, Nanotherapeutics, Inc., Alachua, Florida, United States of America., Talton JD; Research and Development Department, Nanotherapeutics, Inc., Alachua, Florida, United States of America., Cobb RR; Research and Development Department, Nanotherapeutics, Inc., Alachua, Florida, United States of America.
Publikováno v:
PloS one [PLoS One] 2017 May 18; Vol. 12 (5), pp. e0177310. Date of Electronic Publication: 2017 May 18 (Print Publication: 2017).
Autor:
Springer MJ; Research and Development Department, Nanotherapeutics, Inc., Alachua, FL, United States., Ni Y; Research and Development Department, Nanotherapeutics, Inc., Alachua, FL, United States., Finger-Baker I; Research and Development Department, Nanotherapeutics, Inc., Alachua, FL, United States., Ball JP; Research and Development Department, Nanotherapeutics, Inc., Alachua, FL, United States., Hahn J; Research and Development Department, Nanotherapeutics, Inc., Alachua, FL, United States., DiMarco AV; Research and Development Department, Nanotherapeutics, Inc., Alachua, FL, United States., Kobs D; Toxicology Department, Battelle Memorial Institute, West Jefferson, OH, United States., Horne B; Battelle Eastern Science and Technology Center, Aberdeen, MD, United States., Talton JD; Research and Development Department, Nanotherapeutics, Inc., Alachua, FL, United States., Cobb RR; Research and Development Department, Nanotherapeutics, Inc., Alachua, FL, United States. Electronic address: rcobb@nanotherapeutics.com.
Publikováno v:
Vaccine [Vaccine] 2016 Mar 14; Vol. 34 (12), pp. 1452-8. Date of Electronic Publication: 2016 Feb 10.